Postoperative Pain Management in Rhinoplasty

• Status: Enrolling by invitation
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary purpose of the study is to determine adequacy of postoperative pain control after nasal surgery in patients prescribed Acetaminophen (325mg) + Hydrocodone (5mg) compared to Acetaminophen(325mg) + Ibuprofen (200mg)for a period of 5 days after nasal surgery. To assess the degree of pain, the participants will score the intensity of their pain on a visual analog scale(VAS)of 0-100points (0- no pain and 100- most severe pain), preoperatively and postoperatively (to be documented before each dose) for the duration of the prescribed medications .

Additionally, the study will also seek to track:

1. The total number of pills each patients consume from the prescribed 5 day regimen.

2. Any associated side effects.

3. Additional pain medications prescribed in case of inadequate pain control, postoperatively.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Treatments: Acetaminophen; Acetaminophen, hydrocodone drug combination; Hydrocodone; Ibuprofen

Criteria

Inclusion Criteria:

• Minimum age of 18 years

• Able to speak and understand english.

• Undergoing rhinoplasty for cosmetic purposes

• Undergoing rhinoplasty for treatment of nasal obstruction

Exclusion Criteria:

• Less than 18 years of age

• Cannot speak and understand english

• Patients not undergoing nasal surgery.

• Women will be excluded if they are either pregnant or lactating as this population does not undergo nasal surgery at our center.

• Patients with any known allergies to the class of pain medications used in the study.